Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MOREWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MOREUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don’t find the answers you’re looking for, contact us for additional assistance.
EXPLORE MOREThe limited immunogenicity of novel vaccine antigens increases the importance of complementary research in vaccine development. Adjuvants are needed to enhance and prolong the immune response while reducing the amount of antigen required in each dose. Based on multidisciplinary expertise of Creative Biolabs’ scientists including formulation science, immunology, toxicology, and biology, we offer a full range of customized vaccine adjuvant synthesis services, including aluminum, oil adjuvants, bacterial products, ISCOMS, etc. to meet the needs of different customers.
Adjuvant selection depends to a large extent on vaccine formulation and individual application. First, effectiveness and safety are critical in the assisted selection, but many other characteristics of successful adjuvants must be considered, including:
As a leading provider of vaccine services, Creative Biolabs offers a comprehensive range of customized adjuvant synthesis services, including:
| Adjuvants Type | Description |
| Oil emulsions | Usually considered too toxic to humans, oil emulsions such as Freund's complete adjuvant work by creating a depot at the injection site and slowly releasing antigens that trigger the desired immune response. |
| Bacterial-derived adjuvant | Bacterial-derived molecules are a key source of immunostimulatory adjuvants, including lipopolysaccharide (LPS), which contains lipid A, an effective but toxic immunostimulant. |
| Carbohydrate adjuvant | Dextran hydrochloride; mannan from Saccharomyces cerevisiae; chitosan from shrimp shell; β-D-glucan; dextran sulfate sodium salt derived from Leuconostoc. |
| Cytokine adjuvant | Although the use of cytokine adjuvants is limited by toxicity and immunogenicity, they do have the potential to be DNA vaccines co-expressed with antigens. Many cytokines, such as IL-12, stimulate macrophage activation via TLR signaling. |
| Mineral salt adjuvants | Mineral-derived compounds have been used for years as effective antigens, along with aluminum adjuvants. They are commonly referred to as Alum in literature and are widely used in human vaccines. |
| Other adjuvants | Many vaccines use a combination of adjuvants to tailor a specific immune response. Squalene, decane, saponin, poly I:C and many other products have been found to be used alone or in combination with other adjuvants. |
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.
LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MORE
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE
